Page last updated: 2024-08-18

pyrroles and Cutaneous T-Cell Lymphoma

pyrroles has been researched along with Cutaneous T-Cell Lymphoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bonefeld, CM; Fredholm, S; Geisler, C; Gniadecki, R; Iversen, L; Jønson, L; Kopp, KL; Krejsgaard, T; Lindahl, LM; Litvinov, IV; Mongan, NP; Nastasi, C; Odum, N; Petersen, DL; Sasseville, D; Sibbesen, NA; Wasik, MA; Willerslev-Olsen, A; Woetmann, A1

Other Studies

1 other study(ies) available for pyrroles and Cutaneous T-Cell Lymphoma

ArticleYear
Jak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphoma.
    Oncotarget, 2015, Aug-21, Volume: 6, Issue:24

    Topics: Cell Line, Tumor; Genes, Tumor Suppressor; Humans; Janus Kinase 3; Lymphoma, T-Cell, Cutaneous; MicroRNAs; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Signal Transduction; Skin Neoplasms; STAT3 Transcription Factor; STAT5 Transcription Factor; Transfection

2015